Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
topic_facet:"Influenza, Human"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=topic_facet%3A%22Influenza%2C+Human%22
/vufind/Search/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=topic_facet%3A%22Influenza%2C+Human%22
Search /vufind/Search2/Results?join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Influenza%2C+Human%22&type0%5B%5D=Subject&op0%5B%5D=OR&filter%5B%5D=topic_facet%3A%22Influenza%2C+Human%22
PubPharm (2.154)
1
A Study to Learn About a Combined COVID-19 and Influenza Shot in Healthy Adults : A Phase 1/2 Randomized Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Modified RNA COVID-19 Vaccine and a Recombinant Influenza Vaccine Administered as a Single Injection in Healthy Adults 50 Years of Age or Older
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
Immunogenicity of Concomitant Administration of COVID-19 Vaccines With Influenza Vaccines : Immunogenicity of Concomitant Administration of Omicron-containing COVID-19 Vaccines With Influenza Vaccines : In-depth Immunogenicity Analysis.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older : A Phase 3, Randomized, Observer-Blind, Controlled, Multicenter, Clinical Study to Evaluate Immunogenicity and Safety of a MF59-Adjuvanted Quadrivalent Subunit Cell-derived Influenza Vaccine (aQIVc) in Comparison With Quadrivalent Influenza Vaccines, in Adults Aged 50 Years and Older.
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge : Long-Term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
H7N9 Vaccination With and Without AS03 and Unadjuvanted H3N2v Vaccination: Standard and Systems Biology Analyses : A Phase II Study to Evaluate and Compare the Immunogenicity of Monovalent Inactivated Influenza A/H7N9 Virus Vaccine Administered With and Without AS03 Adjuvant and Monovalent Inactivated Influenza A/H3N2v Virus Vaccine Administered Without Adjuvant in Healthy Adults Through Standard and Systems Biology Analyses
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees atBaseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines : Cellular and Molecular Characterization of the Immune Response in Healthy NIH Employees at Baseline, and After Immunization With the H1N1 or Seasonal Influenza Vaccines
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
Screening for LID Clinical Studies Unit Healthy Volunteer Protocols : Screening for LID Clinical Studies Unit Healthy Volunteer Protocols
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Study of the GRIP Influenza and SARS-CoV-2 POC Assays : Clinical Evaluation of the GRIP Influenza and SARS-CoV-2 Point-of-care Assays Using Fresh Patient Nasal Swab Samples
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine : Randomized, Double-Blinded, Placebo-Controlled, Phase 1 Study of the Safety and Immunogenicity of BPL-1357, A BPL-Inactivated, Whole-Virus, Universal Influenza Vaccine
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
10
A Study to Evaluate the Safety and Immunogenicity of COVID-19 Vaccine and Influenza Combination Vaccine : A Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety and Immunogenicity of a SARS CoV 2 rS Nanoparticle and Trivalent Hemagglutinin Nanoparticle Influenza Combination Vaccine With Matrix-M™ Adjuvant in Participants ≥ 50 Years of Age
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
1
2
3
4
5
6
7
8
9
10
11
Nächster »
[216]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Influenza, Human
Medienart
2.118
E-Ressourcen
2.051
Aufsätze
2.050
E-Artikel
103
Bücher
68
E-Books
35
Gedruckte Bücher
1
Gedruckte Aufsätze
1
Hochschulschriften
Alle anzeigen ...
weniger ...
Zeitschriftentitel
2.007
ClinicalTrials.gov
5
Frontiers in Immunology
5
Journal of Korean medical science
5
Vaccine
4
Acta medica portuguesa
3
Maternal and child health journal
2
Clinical journal of the American Society of Nep...
2
Oman medical journal
2
Tuberculosis and respiratory diseases
1
Annals of epidemiology
1
Birth defects research. Part A, Clinical and mo...
1
Emerging Infectious Diseases
1
Epidemiology and infection
1
Frontiers in Cellular and Infection Microbiology
1
Frontiers in Pediatrics
1
Frontiers in Public Health
1
Infection & chemotherapy
1
International Journal of Infectious Diseases
1
International journal of infectious diseases : ...
1
Iranian journal of medical sciences
Alle anzeigen ...
weniger ...
Thema
Influenza, Human
2.007
610
1.724
Study Type: Interventional
1.568
Recruitment Status: Completed
799
Medical Condition: Influenza
380
Phase: Phase 3
360
Phase: Phase 2
308
Phase: Phase 4
289
Phase: Phase 1
274
Study Type: Observational
115
Influenza in Birds
113
Recruitment Status: Recruiting
100
Recruitment Status: Unknown status
96
Communicable Diseases
87
Virus Diseases
86
Medical Condition: Influenza, Human
81
Infection
77
Respiratory Tract Infections
71
Recruitment Status: Active, not recruiting
69
Phase: Phase 1/Phase 2
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
692
2020-
1.320
2010-2019
133
2000-2009
Erscheinungsjahr(e)
Von:
Bis:
Sprache
2.142
Englisch
9
Deutsch
2
Portugiesisch
2
Spanisch
Haven't found what you're looking for?
Wird geladen...